Intronic Single Nucleotide Polymorphisms in the RET Protooncogene Are Associated with a Subset of Apparently Sporadic Pheochromocytoma and May Modulate Age of Onset
Overview
Authors
Affiliations
Approximately 75% of pheochromocytomas are sporadic. Germline mutations in RET, VHL, SDHB, and SDHD have been shown to cause the 25% that are hereditary. Germline high penetrance gain-of-function RET mutations cause multiple endocrine neoplasia type 2, of which medullary thyroid carcinoma (MTC) and pheochromocytoma are components, whereas loss-of-function mutations cause Hirschprung disease (HSCR). A low-penetrance founder locus, in linkage disequilibrium with a RET ancestral haplotype comprising specific alleles at three intron (IVS) 1 single nucleotide polymorphisms (SNPs) (haplotype 0) and SNP A45A, predisposes to the majority of isolated HSCR. A different low-penetrance locus, in linkage disequilibrium with IVS 1 haplotype 2 and SNP S836S, was associated with a subset of sporadic MTC. We, therefore, sought to determine whether RET might also be a low-penetrance gene for apparently sporadic pheochromocytoma. We analyzed 104 pheochromocytoma cases without germline mutations in RET, VHL, SDHD, and SDHB for their status at A45, S836, three IVS 1 SNPs, and a novel upstream insertion/deletion variant. Pheochromocytoma cases were not associated with either A45A or S836S, but we found that cases were associated with haplotype 0 (P = 0.032). However, unlike HSCR, this pheochromocytoma-associated haplotype 0 was not associated with A45A. Taken together with the strengthening of association with the addition of the 5' insertion/deletion variant data (P = 0.016), our observations suggest the presence of a low-penetrance pheochromocytoma susceptibility locus in a region upstream of the putative loci for HSCR and apparently sporadic MTC.
Case Report of a Prolactinoma in a Patient With a Novel Mutation and Bilateral Pheochromocytomas.
Roszko K, Blouch E, Blake M, Powers J, Tischler A, Hodin R J Endocr Soc. 2017; 1(11):1401-1407.
PMID: 29264463 PMC: 5686672. DOI: 10.1210/js.2017-00135.
Waldmann J, Langer P, Habbe N, Fendrich V, Ramaswamy A, Rothmund M Endocrine. 2009; 35(3):347-55.
PMID: 19399650 DOI: 10.1007/s12020-009-9178-y.
Siraj A, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O J Endocrinol Invest. 2008; 31(10):893-9.
PMID: 19092295 DOI: 10.1007/BF03346438.
Chiquet B, Hashmi S, Henry R, Burt A, Mulliken J, Stal S Eur J Hum Genet. 2008; 17(2):195-204.
PMID: 18716610 PMC: 2874967. DOI: 10.1038/ejhg.2008.149.
Variation in WNT genes is associated with non-syndromic cleft lip with or without cleft palate.
Chiquet B, Blanton S, Burt A, Ma D, Stal S, Mulliken J Hum Mol Genet. 2008; 17(14):2212-8.
PMID: 18413325 PMC: 2852032. DOI: 10.1093/hmg/ddn121.